Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients
Laurus Labs Ltd Q1FY25; 52% fall in Profits
Categories
Biotech & Pharma
Lupin Ltd Q4FY24; 52% rise in Profits
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations,
Wockhardt Ltd Q2FY24; 11% rise in Revenue
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
Sanofi India Ltd Q1FY24; 2% rise in Profits
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q1FY24
Windlas Biotech Ltd Q1FY24; 20% rise in Profits
Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid
Supriya Lifescience Ltd (SUPRIYA) Q4 FY23 Earnings Concall Transcript
Supriya Lifescience Ltd (NSE:SUPRIYA) Q4 FY23 Earnings Concall dated May. 29, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Satish Wagh --
Windlas Biotech Limited (WINDLAS) Q4 FY23 Earnings Concall Transcript
Windlas Biotech Limited (NSE:WINDLAS) Q4 FY23 Earnings Concall dated May. 08, 2023. Corporate Participants: Hitesh Windlass -- Managing Director Komal Gupta -- Chief Executive Officer &
Rossari Biotech Ltd (ROSSARI) Q4 FY23 Earnings Concall Transcript
Rossari Biotech Ltd (NSE:ROSSARI) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Aesha Shah -- Investor Relations Edward Menezes -- Executive Chairman & Co-Founder
Laurus Labs Limited Q4FY23 Earnings
To meet the demands of the international pharmaceutical industry, Laurus Labs primarily provides a comprehensive and integrated portfolio of Active Pharmaceutical Ingredients
Laurus Labs Q3FY23 net profit rises by 32 percent
Pharmaceutical and biotechnology company Laurus Labs reported 32% year-on-year (YoY) rise in profit after tax to INR 203 crore for the quarter
Gufic Biosciences Limited (GUFICBIO) Q3 FY23 Earnings Concall Transcript
Gufic Biosciences Limited (NSE:GUFICBIO) Q3 FY23 Earnings Concall dated Feb. 20, 2023. Corporate Participants: Ami Shah -- Company Secretary Avik Das -- Investor Relations D.B.Roonghta -- Chief Financial
Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Transcript
Supriya Lifescience Ltd (NSE:SUPRIYA) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Satish Wagh -- Chairman and Managing Director Saloni Wagh -- Director Krishna
Windlas Biotech Limited (WINDLAS) Q3 FY23 Earnings Concall Transcript
Windlas Biotech Limited (NSE:WINDLAS) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Hitesh Windlas -- Managing Director Komal Gupta -- Chief Executive Officer and
AMI Organics Ltd (AMIORG) Q3 FY23 Earnings Concall Transcript
AMI Organics Ltd (NSE: AMIORG) Q3 FY23 Earnings Concall dated Feb. 04, 2023 Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Patel -- Chief Executive